EpCAM- and EGFR-Specific Antibody Drug Conjugates for Triple-Negative Breast Cancer Treatment

Triple-negative breast cancer (TNBC) is a group of heterogeneous and refractory breast cancers with the absence of estrogen receptor (ER), progesterone receptor (PgR) and epidermal growth factor receptor 2 (HER2). Over the past decade, antibody drug conjugates (ADCs) have ushered in a new era of tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chaoyu, Sheng, Wenjie, Al-Rawe, Marwah, Mohiuddin, T. M., Niebert, Marcus, Zeppernick, Felix, Meihold-Heerlein, Ivo, Hussain, Ahmad Fawzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181111/
https://www.ncbi.nlm.nih.gov/pubmed/35682800
http://dx.doi.org/10.3390/ijms23116122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181111/
https://www.ncbi.nlm.nih.gov/pubmed/35682800
http://dx.doi.org/10.3390/ijms23116122

Ejemplares similares